Weekly Digest – January 2025 Weekly Digest – January 2025 21 Jan 2025: ArriVent BioPharma enters exclusive license with Lepu Biopharma for MRG007, an Antibody Drug Conjugate for the treatment of Gastrointestinal Cancers ArriVent BioPharma entered to exclusive license agreement […]
Weekly Digest – January 2025 Weekly Digest – January 2025 22 Jan 2025: Vincerx Pharma enters at-the-market equity offering deal Vincerx partnered with H.C. Wainwright & Co. for a $30 million at-the-market equity offering Recently, it terminated sales agreement with […]
Weekly Digest – January 2025 Weekly Digest – January 2025 20 Jan 2025: GI Innovation, LaNova Medicines sign MOU to develop combination therapy for pancreatic cancer GI Innovation & LaNova signed MOU to develop a pancreatic cancer combination therapy with […]
